ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,286, issued on June 30, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).
"Analyte sensors featuring working electrode asperity planing for decreasing interferent signal" was invented by Udo Hoss (San Ramon, Calif.), Mark Stephen Yahnke (Alameda, Calif.), Tahir S. Khan (Fremont, Calif.), Jean-Pierre Babka (Alameda, Calif.) and Owen Daniel Reynolds (Cricklade, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Analyte sensors are being increasingly employed for monitoring various analytes in vivo. Analyte sensors may feature enhancements to address signals obtained from interferent species. Some analyte sensors may comprise an an...